EUVIMEDEUVIMED entdecken
Crossref

Structure-based optimization of orally bioavailable EP300-selective degraders

T. Kim, S.Y. Jang, S. Kang, Y. Lee, J. Shin, A. Park, S. Park, M. Lee, S. Jung, Y.Y. Kim, J. Byun, H. Chon und 1 weitere

European Journal of Cancer · 2026-11 · 248 · 117613

DOI: 10.1016/j.ejca.2026.117613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von T. Kim und 12 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kim, T., Jang, S., Kang, S., Lee, Y., Shin, J., Park, A., Park, S., Lee, M., Jung, S., Kim, Y., Byun, J., Chon, H., & Ahn, Y. (2026). Structure-based optimization of orally bioavailable EP300-selective degraders. European Journal of Cancer, 248, 117613. https://doi.org/10.1016/j.ejca.2026.117613

Vancouver

Kim T, Jang S, Kang S, Lee Y, Shin J, Park A, et al. Structure-based optimization of orally bioavailable EP300-selective degraders. European Journal of Cancer. 2026;248:117613. doi:10.1016/j.ejca.2026.117613

BibTeX
@article{Kim2026,
  author = {Kim, T. and Jang, S.Y. and Kang, S. and Lee, Y. and Shin, J. and Park, A. and Park, S. and Lee, M. and Jung, S. and Kim, Y.Y. and Byun, J. and Chon, H. and Ahn, Y.G.},
  title = {Structure-based optimization of orally bioavailable EP300-selective degraders},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117613},
  doi = {10.1016/j.ejca.2026.117613}
}
Kostenlos starten →